FDA Adverse Event Malfunction Summary report: N

COULTER® LH 500 HEMATOLOGY ANALYZER

MDR report key: 2544011 · Received April 20, 2012

Report

Report Number
1061932-2012-01380
Event Type
Malfunction
Date Received
April 20, 2012
Date of Event
March 27, 2012
Report Date
March 27, 2012
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K032000
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A FIELD SERVICE ENGINEER (FSE) FOUND TUBING FROM VALVE (VL-43) WAS LEAKING AND REPLACED ALL CENTRAL PANEL TUBING. PER LABELING, BECKMAN COULTER, INC. URGES ITS CUSTOMERS TO COMPLY WITH ALL NATIONAL HEALTH AND SAFETY STANDARDS SUCH AS THE USE OF BARRIER PROTECTION. THIS MAY INCLUDE, BUT IT IS NOT LIMITED TO, PROTECTIVE EYEWEAR, GLOVES, AND SUITABLE LABORATORY ATTIRE WHEN OPERATING OR MAINTAINING THIS OR ANY OTHER AUTOMATED LABORATORY ANALYZER. THE CAUSE OF THE LEAK IS ATTRIBUTED TO TUBING AT VL-43. (B)(4).

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC., (BEC) REPORTING THAT APPROXIMATELY 30ML OF BLUE FLUID DRIPPED FROM UNDER THE COULTER LH 500 HEMATOLOGY ANALYZER. THE FLUID WAS NOT CONTAINED. THE OPERATOR WAS WEARING PERSONAL PROTECTIVE EQUIPMENT (PPE), CONSISTING OF A LAB COAT AND GLOVES, WITHOUT FACE PROTECTION. THE CUSTOMER REPORTED THERE WAS NO CONTACT TO OPEN OR BROKEN SKIN OR MUCOUS MEMBRANES SUCH AS THE EYE, NOSE OR MOUTH. MEDICAL ATTENTION WAS NOT SOUGHT. THERE IS AN EXPOSURE CONTROL/RISK MANAGEMENT PLAN IN PLACE AT THE FACILITY. THERE WERE NO PATIENT RESULTS AFFECTED AND THERE WERE NO ERRONEOUS RESULTS REPORTED OUT OF THE LAB. NO DEATH OR INJURY IS ASSOCIATED WITH THIS EVENT AND THERE WAS NO CHANGE TO PATIENT TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER® LH 500 HEMATOLOGY ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER, INC. N/A

Patients

Seq Age Sex Outcome Treatment
1